Live Breaking News & Updates on Valsartan Patent Litig
Stay updated with breaking news from Valsartan patent litig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court’s decision in Amgen Inc. v. Sanofi found that antibody claims defined by their binding and blocking function lacked enablement..The consensus seems to be that Amgen generally forecloses broad genus claims in the biotechnology field. ....